Novavax begins phase one of coronavirus vaccine trial after $388M Gates-backed group funding

Novavax has begun phase one of its clinical trail for a coronavirus vaccine candidate. Yahoo Finance’s Anjalee Khemlani breaks down the latest developments. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.